174 related articles for article (PubMed ID: 35182045)
1. Effect of Roxadustat on the Pharmacokinetics of Simvastatin, Rosuvastatin, and Atorvastatin in Healthy Subjects: Results From 3 Phase 1, Open-Label, 1-Sequence, Crossover Studies.
Groenendaal-van de Meent D; den Adel M; Kerbusch V; van Dijk J; Shibata T; Kato K; Schaddelee M
Clin Pharmacol Drug Dev; 2022 Apr; 11(4):486-501. PubMed ID: 35182045
[TBL] [Abstract][Full Text] [Related]
2. Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?
Birmingham BK; Bujac SR; Elsby R; Azumaya CT; Wei C; Chen Y; Mosqueda-Garcia R; Ambrose HJ
Eur J Clin Pharmacol; 2015 Mar; 71(3):341-55. PubMed ID: 25673568
[TBL] [Abstract][Full Text] [Related]
3. Effect of Upadacitinib on the Pharmacokinetics of Rosuvastatin or Atorvastatin in Healthy Subjects.
Mohamed MF; Coppola S; Feng T; Camp HS; Kim E; Othman AA
Clin Pharmacol Drug Dev; 2021 Nov; 10(11):1335-1344. PubMed ID: 34109764
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the effect of lanthanum carbonate hydrate on the pharmacokinetics of roxadustat in non-elderly healthy adult male subjects.
Shibata T; Nomura Y; Takada A; Aoki S; Katashima M; Murakami H
J Clin Pharm Ther; 2018 Oct; 43(5):633-639. PubMed ID: 29981285
[TBL] [Abstract][Full Text] [Related]
5. Effect of Steady-State Faldaprevir on Pharmacokinetics of Atorvastatin or Rosuvastatin in Healthy Volunteers: A Prospective Open-Label, Fixed-Sequence Crossover Study.
Huang F; Marzin K; Koenen R; Kammerer KP; Strelkowa N; Elgadi M; Quinson AM; Haertter S
J Clin Pharmacol; 2017 Oct; 57(10):1305-1314. PubMed ID: 28513969
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of Food and Spherical Carbon Adsorbent Effects on the Pharmacokinetics of Roxadustat in Healthy Nonelderly Adult Male Japanese Subjects.
Shibata T; Nomura Y; Takada A; Ueno M; Katashima M; Yazawa R; Furihata K
Clin Pharmacol Drug Dev; 2019 Apr; 8(3):304-313. PubMed ID: 29966038
[TBL] [Abstract][Full Text] [Related]
7. Understanding Statin-Roxadustat Drug-Drug-Disease Interaction Using Physiologically-Based Pharmacokinetic Modeling.
Dong J; Prieto Garcia L; Huang Y; Tang W; Lundahl A; Elebring M; Ahlström C; Vildhede A; Sjögren E; Någård M
Clin Pharmacol Ther; 2023 Oct; 114(4):825-835. PubMed ID: 37376792
[TBL] [Abstract][Full Text] [Related]
8. Effect of Multiple Doses of Omeprazole on the Pharmacokinetics, Safety, and Tolerability of Roxadustat in Healthy Subjects.
Groenendaal-van de Meent D; den Adel M; van Dijk J; Barroso-Fernandez B; El Galta R; Golor G; Schaddelee M
Eur J Drug Metab Pharmacokinet; 2018 Dec; 43(6):685-692. PubMed ID: 29752643
[TBL] [Abstract][Full Text] [Related]
9. Assessment of pharmacokinetic interaction between omega-3 carboxylic acids and the statins rosuvastatin and simvastatin: Results of 2 phase I studies in healthy volunteers.
Offman E; Davidson M; Nilsson C
J Clin Lipidol; 2017; 11(3):739-748. PubMed ID: 28506390
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Pharmacokinetic Drug Interactions of the Direct-Acting Antiviral Agents Elbasvir and Grazoprevir with Pitavastatin, Rosuvastatin, Pravastatin, and Atorvastatin in Healthy Adults.
Caro L; Prueksaritanont T; Fandozzi CM; Feng HP; Guo Z; Wolford D; Panebianco D; Fraser IP; Levine V; Swearingen D; Butterton JR; Iwamoto M; Yeh WW
Clin Drug Investig; 2021 Feb; 41(2):133-147. PubMed ID: 33527237
[TBL] [Abstract][Full Text] [Related]
11. Effect of Kidney Function and Dialysis on the Pharmacokinetics and Pharmacodynamics of Roxadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor.
Groenendaal-van de Meent D; Kerbusch V; Kaspera R; Barroso-Fernandez B; Galletti P; Klein GK; den Adel M
Eur J Drug Metab Pharmacokinet; 2021 Jan; 46(1):141-153. PubMed ID: 33165773
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the Effect of Filgotinib on the Pharmacokinetics of Atorvastatin, Pravastatin, and Rosuvastatin in Healthy Adult Participants.
Anderson K; Nelson CH; Gong Q; Alani M; Tarnowski T; Othman AA
Clin Pharmacol Drug Dev; 2022 Feb; 11(2):235-245. PubMed ID: 34468080
[TBL] [Abstract][Full Text] [Related]
13. Effect of DS-8500a, a Novel G Protein-Coupled Receptor 119 Agonist, on the Pharmacokinetics of Rosuvastatin and Atorvastatin in Healthy Subjects.
Maekawa Y; Furuie H; Kato M; Myobatake Y; Kamiyama E; Watanabe A; Shiosakai K; Taguchi T; Bass R; Zhou J; Dishy V; Warren V; Vashi V; Ishizuka H
Clin Drug Investig; 2019 Oct; 39(10):967-978. PubMed ID: 31321631
[TBL] [Abstract][Full Text] [Related]
14. Effects of Fostamatinib on the Pharmacokinetics of Oral Contraceptive, Warfarin, and the Statins Rosuvastatin and Simvastatin: Results From Phase I Clinical Studies.
Martin P; Gillen M; Ritter J; Mathews D; Brealey C; Surry D; Oliver S; Holmes V; Severin P; Elsby R
Drugs R D; 2016 Mar; 16(1):93-107. PubMed ID: 26748647
[TBL] [Abstract][Full Text] [Related]
15. Effect of the Phosphate Binders Sevelamer Carbonate and Calcium Acetate on the Pharmacokinetics of Roxadustat After Concomitant or Time-separated Administration in Healthy Individuals.
Groenendaal-van de Meent D; Kerbusch V; Barroso-Fernandez B; den Adel M; van Dijk J; Golor G; Schaddelee M
Clin Ther; 2021 Jun; 43(6):1079-1091. PubMed ID: 33962762
[TBL] [Abstract][Full Text] [Related]
16. Assessment of Anti-Xa activity in patients receiving concomitant apixaban with strong p-glycoprotein inhibitors and statins.
Milner E; Ainsworth M; Gleaton M; Bookstaver D
J Clin Pharm Ther; 2022 May; 47(5):668-675. PubMed ID: 35032137
[TBL] [Abstract][Full Text] [Related]
17. Fevipiprant has a low risk of influencing co-medication pharmacokinetics: Impact on simvastatin and rosuvastatin in different SLCO1B1 genotypes.
Poller B; Woessner R; Barve A; Tillmann HC; Vemula J; Nica A; Elbast W; Schiller H; End P; Camenisch G; Weiss M
Pulm Pharmacol Ther; 2019 Aug; 57():101809. PubMed ID: 31195091
[TBL] [Abstract][Full Text] [Related]
18. The Effect of BI 730357 (Retinoic Acid-Related Orphan Receptor Gamma t Antagonist, Bevurogant) on the Pharmacokinetics of a Transporter Probe Cocktail, Including Digoxin, Furosemide, Metformin, and Rosuvastatin: An Open-Label, Non-randomized, 2-Period Fixed-Sequence Trial in Healthy Subjects.
Choi H; Huang F; Flack M
Clin Pharmacol Drug Dev; 2024 Feb; 13(2):197-207. PubMed ID: 37960990
[TBL] [Abstract][Full Text] [Related]
19. The Hypoxia-inducible Factor Prolyl-Hydroxylase Inhibitor Roxadustat (FG-4592) and Warfarin in Healthy Volunteers: A Pharmacokinetic and Pharmacodynamic Drug-Drug Interaction Study.
Groenendaal-van de Meent D; den Adel M; Rijnders S; Krebs-Brown A; Kerbusch V; Golor G; Schaddelee M
Clin Ther; 2016 Apr; 38(4):918-28. PubMed ID: 26947173
[TBL] [Abstract][Full Text] [Related]
20. Effect of Macitentan on the Pharmacokinetics of the Breast Cancer Resistance Protein Substrates, Rosuvastatin and Riociguat, in Healthy Male Subjects.
Csonka D; Bruderer S; Schultz A; Soergel M; Stepanova R; Sabattini G; Perez-Ruixo JJ
Clin Drug Investig; 2019 Dec; 39(12):1223-1232. PubMed ID: 31552642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]